Laparoscopic Hysterectomy
Conditions
Keywords
ovarian function tests
Brief summary
The purpose of this study is to assess the feasibility of performing a randomized clinical trial evaluating the effect of salpingectomy (removal of the fallopian tubes) during laparoscopic hysterectomy on ovarian function. The hypothesis is that removal of the tubes can prevent diseases of the fallopian tubes such as infection, hydrosalpinx (fluid-filled tubes)and additional invasive procedures such as further imaging work-ups and further surgery related to the tubes.
Interventions
Removal of the fallopian tubes
Sponsors
Study design
Eligibility
Inclusion criteria
* Women ages 18-45 scheduled for laparoscopic hysterectomy with planned preservation of both ovaries.
Exclusion criteria
* Carrier for the gene that codes for breast cancer type 1 susceptibility protein (BRCA1) or the gene that codes for breast cancer type 2 susceptibility protein (BRCA 2). * Personal history of gynecologic cancer * Pregnancy * Non-English speaking * Unable to provide informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change from baseline in ovarian function as measured by Anti-Mullerian Hormone (AMH) | AMH blood samples collected prior to surgery at day 1 (the day of the surgery) and at 1 and 3 months after day 1. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient demographics | Prior to surgery | The following routinely collected information will be included in the data analysis: age, body mass index, and surgery indication. |
| Patient surgical outcomes | Postoperatively on day 1 | The following surgical outcomes will be collected postoperatively: total operating time, estimated blood loss, surgical complications, and surgical pathology. |
Countries
United States